123 related articles for article (PubMed ID: 16133665)
1. Predictive value of the time-intensity curves on dynamic contrast-enhanced magnetic resonance imaging for lymphatic spreading in breast cancer.
Komatsu S; Lee CJ; Ichikawa D; Hamashima T; Morofuji N; Shirono K; Hosokawa Y; Okabe H; Kurioka H; Yamagishi H; Oka T
Surg Today; 2005; 35(9):720-4. PubMed ID: 16133665
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intraductal spread on dynamic contrast-enhanced MRI with clinicopathologic features in breast cancer.
Komatsu S; Lee CJ; Hosokawa Y; Ichikawa D; Hamashima T; Shirono K; Okabe H; Kurioka H; Oka T
Jpn J Clin Oncol; 2004 Sep; 34(9):515-8. PubMed ID: 15466824
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
[TBL] [Abstract][Full Text] [Related]
5. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
7. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound.
Abe H; Schacht D; Kulkarni K; Shimauchi A; Yamaguchi K; Sennett CA; Jiang Y
Acad Radiol; 2013 Nov; 20(11):1399-404. PubMed ID: 24119352
[TBL] [Abstract][Full Text] [Related]
10. Real-time MRI navigated US: role in diagnosis and guided biopsy of incidental breast lesions and axillary lymph nodes detected on breast MRI but not on second look US.
Pons EP; Azcón FM; Casas MC; Meca SM; Espona JLG
Eur J Radiol; 2014 Jun; 83(6):942-950. PubMed ID: 24725672
[TBL] [Abstract][Full Text] [Related]
11. [Distinguishing benign and malignant lesions with time-signal intensity curve of dynamic contrast-enhanced breast MRI scanning].
Yuan HM; Yu JQ; Chu ZG; Peng LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):556-9. PubMed ID: 21866648
[TBL] [Abstract][Full Text] [Related]
12. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
[TBL] [Abstract][Full Text] [Related]
14. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
15. Parametric MR dynamic imaging for breast lesions characterization and prediction of lymph nodes involvement.
Ciarmiello A; Gaeta MC; Meniconi M; Milano A; Alfano B; Del Vecchio S; Salvatore M
Curr Radiopharm; 2014; 7(2):91-9. PubMed ID: 25382545
[TBL] [Abstract][Full Text] [Related]
16. [Three-dimentional volumetric interpolated breath-hold magnetic resonance imaging for the diagnosis of breast tumors].
Nakayama S; Kakizaki D; Kaise H; Kusama M; Ishikawa A; Amino M; Koyanagi Y; Abe K; Iwaya K
Nihon Rinsho; 2004 Apr; 62(4):790-8. PubMed ID: 15106351
[TBL] [Abstract][Full Text] [Related]
17. Value of magnetic resonance imaging including dynamic contrast-enhanced magnetic resonance imaging in differentiation between inverted papilloma and malignant tumors in the nasal cavity.
Wang X; Zhang Z; Chen X; Li J; Xian J
Chin Med J (Engl); 2014; 127(9):1696-701. PubMed ID: 24791877
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma.
Teng F; Zhang YF; Wang YM; Yu J; Lang X; Tian WY; Jiang CX; Xue FX
Acta Obstet Gynecol Scand; 2015 Mar; 94(3):266-73. PubMed ID: 25545203
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
Koh DM; George C; Temple L; Collins DJ; Toomey P; Raja A; Bett N; Farhat S; Husband JE; Brown G
AJR Am J Roentgenol; 2010 Jun; 194(6):W505-13. PubMed ID: 20489069
[TBL] [Abstract][Full Text] [Related]
20. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
